Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals, Cell, vol.50, issue.3, pp.509-526, 1987. ,
Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, vol.51, issue.6, pp.919-947, 1987. ,
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface, Cell, vol.54, issue.4, pp.447-52, 1988. ,
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle, Nature, vol.333, issue.6172, pp.466-475, 1988. ,
The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin, J Cell Biol, vol.150, issue.5, pp.1209-1223, 2000. ,
Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin, J Clin Invest, vol.92, issue.2, pp.866-71, 1993. ,
Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats, J Physiol, vol.589, pp.1195-208, 2011. ,
mdx' mouse myopathy: histopathological, morphometric and histochemical observations on young mice, J Comp Pathol, vol.102, issue.3, pp.249-63, 1990. ,
Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K+ channels, Proc Natl Acad Sci, vol.97, issue.9, pp.4950-4955, 2000. ,
Calcium and the damage pathways in muscular dystrophy, Can J Physiol Pharmacol, vol.88, issue.2, pp.83-91, 2010. ,
Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil, Am J Physiol Heart Circ Physiol, vol.300, issue.1, pp.144-53, 2011. ,
AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm, Am J Pathol, vol.181, issue.2, pp.583-92, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02546568
Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition, Hum Mol Genet, vol.22, issue.1, pp.153-67, 2013. ,
Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state, J Neurol Sci, vol.161, issue.1, pp.77-84, 1998. ,
Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse, PloS One, vol.5, issue.12, p.15354, 2010. ,
Microtubules underlie dysfunction in duchenne muscular dystrophy, Sci Signal, vol.5, issue.236, p.56, 2012. ,
Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice, Neuromuscul Disord NMD, vol.16, issue.9, pp.591-602, 2006. ,
Cromolyn administration (to block mast cell degranulation) reduces necrosis of dystrophic muscle in mdx mice, Neurobiol Dis, vol.23, issue.2, pp.387-97, 2006. ,
Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy, Hum Mol Genet, vol.18, issue.3, pp.482-96, 2009. ,
Dystrophin expression in muscle stem cells regulates their polarity and asymetric division, Nat Med, vol.21, issue.12, pp.1455-1463, 2015. ,
Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy, Somat Cell Mol Genet, vol.16, issue.6, pp.557-65, 1990. ,
Satellite cells from dystrophic (mdx) mice display accelerated differentiation in primary cultures and in isolated myofibers, Dev Dyn Off Publ Am Assoc Anat, vol.235, issue.1, pp.203-215, 2006. ,
Reciprocal amplification of ROS and Ca(2+) signals in stressed mdx dystrophic skeletal muscle fibers, Pflüg Arch Eur J Physiol, vol.458, issue.5, pp.915-943, 2009. ,
Managing Duchenne muscular dystrophy--the additive effect of spinal surgery and home nocturnal ventilation in improving survival, Neuromuscul Disord NMD, vol.17, issue.6, pp.470-475, 2007. ,
Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients. Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol Ed Gaetano Conte Acad Study Striated Muscle Dis, vol.31, pp.121-126, 2012. ,
Rescue of dystrophic muscle through U7 snRNAmediated exon skipping, Science, vol.306, issue.5702, pp.1796-1805, 2004. ,
Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice, Mol Ther J Am Soc Gene Ther, vol.16, issue.4, pp.657-64, 2008. ,
Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy, Mol Ther J Am Soc Gene Ther, vol.21, issue.4, pp.750-757, 2013. ,
Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients, Mol Ther J Am Soc Gene Ther, vol.22, issue.11, pp.1923-1958, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02447482
Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD), Curr Gene Ther, vol.15, issue.4, pp.395-415, 2015. ,
Dystrophin immunity in Duchenne's muscular dystrophy, N Engl J Med, vol.363, issue.15, pp.1429-1466, 2010. ,
Immune responses to AAV vectors: overcoming barriers to successful gene therapy, Blood, vol.122, issue.1, pp.23-36, 2013. ,
Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy, J Clin Invest, vol.125, issue.2, pp.870-80, 2015. ,
Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle, Genet Vaccines Ther, vol.6, p.14, 2008. ,
AAV Genome Loss From Dystrophic Mouse Muscles During AAV-U7 snRNA-mediated Exon-skipping Therapy, Mol Ther J Am Soc Gene Ther, 2013. ,
Short-lived recombinant adeno-associated virus transgene expression in dystrophic muscle is associated with oxidative damage to transgene mRNA, Mol Ther Methods Clin Dev, vol.2, p.15010, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01799048
Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product, Gene Ther, vol.9, issue.23, pp.1576-88, 2002. ,
Soluble TNF-? receptor secretion from healthy or dystrophic mice after AAV6-mediated muscle gene transfer, Gene Ther, vol.17, issue.11, pp.1400-1410, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02495337
Hyaluronidase enhances recombinant adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle, Gene Ther, vol.7, issue.16, pp.1417-1437, 2000. ,
Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle, Mol Ther J Am Soc Gene Ther, vol.16, issue.7, pp.1291-1300, 2008. ,
Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues, Mol Ther J Am Soc Gene Ther, vol.20, issue.2, pp.317-345, 2012. ,
Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma, FASEB J Off Publ Fed Am Soc Exp Biol, vol.21, issue.9, pp.2195-204, 2007. ,
Histopathological features of muscle in the preclinical stages of muscular dystrophy, Brain J Neurol, vol.85, pp.109-129, 1962. ,
,
Structural changes in the early stages of Duchenne muscular dystrophy, J Neurol Neurosurg Psychiatry, vol.35, issue.4, pp.451-456, 1972. ,
Human galectin 3 binding protein interacts with recombinant adenoassociated virus type 6, J Virol, vol.86, issue.12, pp.6620-6651, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02881163
C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice, J Virol, vol.87, pp.10784-91, 2013. ,
Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients, Hum Mol Genet, vol.23, issue.24, pp.6458-69, 2014. ,
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies, Hum Mol Genet, vol.24, issue.17, pp.4916-4948, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01226478
A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6 and 8, Mol Ther, vol.19, issue.11, pp.2084-2091, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02881133
Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery, Mol Ther, vol.22, issue.2, pp.338-347, 2014. ,
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys, Sci Transl Med, vol.5, pp.194-92, 0194. ,
URL : https://hal.archives-ouvertes.fr/hal-02881152
Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy, Cell, vol.82, issue.5, pp.743-52, 1995. ,
Transcriptional profiles from patients with dystrophinopathies and limb girdle muscular dystrophies as determined by qRT-PCR, J Neurol, vol.251, issue.1, pp.72-80, 2004. ,
Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy, Proc Natl Acad Sci, vol.97, issue.25, pp.13818-13841, 2000. ,
Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency, Proc Natl Acad Sci, vol.105, pp.7028-7061, 2008. ,
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy, Proc Natl Acad Sci, vol.107, issue.44, pp.19079-83, 2010. ,
Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy, J Pathol, vol.228, issue.1, pp.77-87, 2012. ,
PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy, Neurology, vol.82, issue.23, pp.2085-91, 2014. ,
Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery, Gene Ther, vol.20, issue.9, pp.930-938, 2013. ,
Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin, vol.103, pp.864-70, 2001. ,
URL : https://hal.archives-ouvertes.fr/inserm-00135482
Vasodilation of intramuscular arterioles under shear stress in dystrophin-deficient skeletal muscle is impaired through decreased nNOS expression ,
, Acta Myol Myopathies Cardiomyopathies Off J Mediterr Soc Myol Ed Gaetano Conte Acad Study Striated Muscle Dis, vol.27, pp.30-36, 2008.
Increased neointimal thickening in dystrophin-deficient mdx mice, PloS One, vol.7, issue.1, p.29904, 2012. ,
Enhanced arteriogenesis and wound repair in dystrophindeficient mdx mice, Circulation, vol.110, issue.21, pp.3341-3349, 2004. ,
Structural and Functional Alterations of Skeletal Muscle Microvasculature in Dystrophin-Deficient mdx Mice, Am J Pathol, vol.185, issue.9, pp.2482-94, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01151848
The potential of adenoassociated viral vectors for gene delivery to muscle tissue, Expert Opin Drug Deliv, vol.11, issue.3, pp.345-64, 2014. ,
Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention, PM R, vol.1, issue.8, pp.755-68, 2009. ,
Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cellmediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies, Hum Pathol, vol.17, issue.7, pp.704-725, 1986. ,
Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy, J Neurol Sci, vol.99, issue.2-3, pp.199-217, 1990. ,
A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice, Hum Mol Genet, vol.11, issue.3, pp.263-72, 2002. ,
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression, FASEB J Off Publ Fed Am Soc Exp Biol, vol.21, issue.4, pp.1210-1236, 2007. ,
Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders, Lancet Lond Engl, vol.1, issue.8425, pp.361-364, 1985. ,
Expression of class I and class II MHC antigens in neuromuscular diseases, J Neurol Sci, vol.89, issue.2-3, pp.213-239, 1989. ,
Analysis of T cell receptor repertoire of muscleinfiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection, J Clin Invest, vol.91, issue.6, pp.2880-2886, 1993. ,
Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy, J Immunol Baltim Md, vol.153, issue.10, pp.4798-805, 1950. ,
Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle, Clin Immunol Orlando Fla, vol.98, issue.2, pp.235-278, 2001. ,
A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice, J Cell Biol, vol.155, issue.1, pp.123-154, 2001. ,
AAVbased shRNA silencing of NF-?B ameliorates muscle pathologies in mdx mice, Gene Ther, vol.19, issue.12, pp.1196-204, 2012. ,
Regulatory T cell suppress muscle inflammation and injury in muscular dystrophy, Sci Transl Med, vol.6, issue.258, pp.258-142, 2014. ,
The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer, Curr Gene Ther, vol.15, issue.4, pp.381-94, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02880969
A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy, Sci Transl Med, vol.2, issue.42, pp.42-54, 2010. ,
Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10, Hum Mol Genet, vol.23, issue.15, pp.3990-4000, 2014. ,
Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy, PloS One, vol.9, issue.10, p.110371, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01190124
Intracellular transport of recombinant adeno-associated virus vectors, Gene Ther, vol.19, issue.6, pp.649-58, 2012. ,
Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions, J Virol, vol.72, issue.2, pp.1438-1483, 1998. ,
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2, Nat Med, vol.5, issue.1, pp.71-78, 1999. ,
AlphaVbeta5 integrin: a coreceptor for adeno-associated virus type 2 infection, Nat Med, vol.5, issue.1, pp.78-82, 1999. ,
Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection, J Virol, vol.79, issue.1, pp.609-623, 2005. ,
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9, J Virol, vol.80, issue.19, pp.9831-9837, 2006. ,
Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry, J Virol, vol.80, issue.18, pp.8961-8970, 2006. ,
Molecular characterization of adeno-associated viruses infecting children, J Virol, vol.79, issue.23, pp.14781-92, 2005. ,
An essential receptor for adeno-associated virus infection, Nature, vol.530, pp.108-120, 2016. ,
Syndecan-1 expression is down-regulated during myoblast terminal differentiation. Modulation by growth factors and retinoic acid, J Biol Chem, vol.272, issue.29, pp.18418-18442, 1997. ,
Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factordependent mechanism, J Biol Chem, vol.274, issue.53, pp.37876-84, 1999. ,
Synthesis and processing of glypican during differentiation of skeletal muscle cells, Eur J Cell Biol, vol.71, issue.2, pp.170-176, 1996. ,
Synthesis of proteoglycans is augmented in dystrophic mdx mouse skeletal muscle, Eur J Cell Biol, vol.79, issue.3, pp.173-81, 2000. ,
Augmented synthesis and differential localization of heparan sulfate proteoglycans in Duchenne muscular dystrophy, J Cell Biochem, vol.85, issue.4, pp.703-716, 2002. ,
Dynamin is required for recombinant adeno-associated virus type 2 infection, J Virol, vol.73, issue.12, pp.10371-10377, 1999. ,
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors, J Virol, vol.74, issue.6, pp.2777-85, 2000. ,
Endocytosis and nuclear trafficking of adenoassociated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation, J Virol, 2000. ,
Novel approaches to augment adeno-associated virus type-2 endocytosis and transduction, Virus Res, vol.104, issue.1, pp.51-60, 2004. ,
Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway, Cell Host Microbe, vol.10, issue.6, pp.563-76, 2011. ,
Adenoassociated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus, J Virol, vol.80, issue.22, pp.11040-54, 2006. ,
Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles, Virology, vol.409, issue.1, pp.77-83, 2011. ,
Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation, J Virol, vol.75, issue.4, pp.1824-1857, 2001. ,
Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction, J Virol, vol.89, issue.3, pp.1673-87, 2015. ,
Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells, J Virol, vol.76, issue.22, pp.11530-11570, 2002. ,
rAAV2 traffics through both the late and the recycling endosomes in a dosedependent fashion, Mol Ther J Am Soc Gene Ther, vol.13, issue.4, pp.671-82, 2006. ,
Unique characteristics of AAV1, 2, and 5 viral entry, intracellular trafficking, and nuclear import define transduction efficiency in HeLa cells, Hum Gene Ther, vol.22, issue.11, pp.1433-1477, 2011. ,
Endocytosis of adenoassociated virus type 5 leads to accumulation of virus particles in the Golgi compartment, J Virol, vol.76, issue.5, pp.2340-2349, 2002. ,
Dystrophin protects the sarcolemma from stresses developed during muscle contraction, Proc Natl Acad Sci, vol.90, issue.8, pp.3710-3714, 1993. ,
Morphological changes in dystrophic muscle, Br Med Bull, vol.36, issue.2, pp.145-122, 1980. ,
Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy, Acta Neuropathol (Berl), vol.77, issue.1, pp.69-81, 1988. ,
rAAV6-microdystrophin rescues aberrant Golgi complex organization in mdx skeletal muscles, Traffic Cph Den, vol.8, issue.10, pp.1424-1463, 2007. ,
Autophagy as a new therapeutic target in Duchenne muscular dystrophy, Cell Death Dis, vol.3, p.418, 2012. ,
Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice, PLoS Curr, vol.5, 2013. ,
Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy, Nat Commun, vol.5, p.4425, 2014. ,
Dystrophin deficiency leads to disturbance of LAMP1-vesicleassociated protein secretion, Cell Mol Life Sci CMLS, vol.70, issue.12, pp.2159-74, 2013. ,
Notch1 augments intracellular trafficking of adeno-associated virus type 2, J Virol, vol.81, issue.4, pp.2069-73, 2007. ,
Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling, BMC Genomics, vol.6, p.98, 2005. ,
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy, Exp Physiol, vol.99, issue.4, pp.675-87, 2014. ,
Notch signaling deficiency underlies age-dependent depletion of satellite cells in muscular dystrophy, Dis Model Mech, vol.7, issue.8, pp.997-1004, 2014. ,
Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype, Cell, vol.163, issue.5, pp.1204-1217, 2015. ,
A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis, Mol Ther J Am Soc Gene Ther, vol.15, issue.7, pp.1323-1353, 2007. ,
Singlepolarity recombinant adeno-associated virus 2 vector-mediated transgene expression in vitro and in vivo: mechanism of transduction. Restriction factors against rAAV in DMD muscles, Journal Name, vol.0, issue.0, p.15, 2015. ,
, Mol Ther J Am Soc Gene Ther, vol.16, issue.2, pp.290-295, 2008.
Characterization of Ca2+ channels involved in ET-1-induced transactivation of EGF receptors, Am J Physiol Heart Circ Physiol, vol.283, issue.6, pp.2671-2676, 2002. ,
Involvement of extracellular Ca2+ influx and epidermal growth factor receptor tyrosine kinase transactivation in endothelin-1-induced arachidonic acid release, Br J Pharmacol, vol.139, issue.8, pp.1516-1538, 2003. ,
Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network, J Virol, vol.86, pp.10462-73, 2012. ,
Microtubule binding distinguishes dystrophin from utrophin, Proc Natl Acad Sci, vol.111, issue.15, pp.5723-5731, 2014. ,
Dystrophin is a microtubule-associated protein, J Cell Biol, vol.186, issue.3, pp.363-372, 2009. ,
Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2, J Virol, vol.76, issue.22, pp.11505-11522, 2002. ,
Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus, J Virol, vol.88, issue.8, pp.4132-4176, 2014. ,
LINC complex alterations in DMD and EDMD/CMT fibroblasts, Eur J Cell Biol, vol.91, issue.8, pp.614-642, 2012. ,
Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates, Mol Ther J Am Soc Gene Ther, vol.17, issue.3, pp.516-539, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02659213
Purification of host cell enzymes involved in adeno-associated virus DNA replication, J Virol, vol.81, issue.11, pp.5777-87, 2007. ,
Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression, J Virol, vol.75, issue.19, pp.8968-76, 2001. ,
Role of tyrosine phosphorylation of a cellular protein in adenoassociated virus 2-mediated transgene expression, Proc Natl Acad Sci, vol.94, issue.20, pp.10879-84, 1997. ,
Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression, J Virol, vol.72, issue.12, pp.9835-9878, 1998. ,
Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo, J Virol, vol.77, issue.4, pp.2741-2747, 2003. ,
Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo, J Virol, vol.72, issue.2, pp.1593-1602, 1998. ,
Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice, Nature, vol.335, issue.6192, pp.735-743, 1988. ,
Calcium entry through stretch-inactivated ion channels in mdx myotubes, Nature, vol.344, issue.6267, pp.670-673, 1990. ,
Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers, J Cell Biol, vol.158, issue.6, pp.1089-96, 2002. ,
Genetic fate of recombinant adeno-associated virus vector genomes in muscle, J Virol, vol.77, issue.6, pp.3495-504, 2003. ,
Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle, J Virol, vol.82, issue.16, pp.7875-85, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-02666015
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector, J Virol, vol.70, issue.11, pp.8098-108, 1996. ,
Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice, Hum Gene Ther, vol.8, issue.16, pp.1891-900, 1997. ,
Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle, J Virol, vol.73, issue.3, pp.1949-55, 1999. ,
The Role of DNA Repair Pathways in Adeno-Associated Virus Infection and Viral Genome Replication / Recombination / Integration, 2011. ,
Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle, Proc Natl Acad Sci, vol.98, issue.7, pp.4084-4092, 2001. ,
Differential effects of DNA double-strand break repair pathways on single-strand and self-complementary adeno-associated virus vector genomes, J Virol, vol.84, issue.17, pp.8673-82, 2010. ,
The Mre11/Rad50/Nbs1 complex limits adenoassociated virus transduction and replication, J Virol, vol.81, issue.23, pp.12936-12981, 2007. ,
Hairpin-end conformation of adenoassociated virus genome determines interactions with DNA-repair pathways, Gene Ther, vol.20, issue.6, pp.686-93, 2013. ,
Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins, Mol Ther J Am Soc Gene Ther, vol.20, issue.11, pp.2087-97, 2012. ,
DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies, PLoS Genet, vol.7, issue.4, p.1002042, 2011. ,
Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts, Am J Pathol, vol.176, issue.1, pp.416-450, 2010. ,
Insight into the mechanism of inhibition of adeno-associated virus by the Mre11/Rad50/Nbs1 complex, J Virol, vol.89, issue.1, pp.181-94, 2015. ,
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase, Proc Natl Acad Sci U S A, vol.94, issue.11, pp.5798-803, 1997. ,
A histone deacetylase inhibitor enhances recombinant adeno-associated virus-mediated gene expression in tumor cells, Mol Ther J Am Soc Gene Ther, vol.13, issue.4, pp.738-784, 2006. ,
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors, Nat Med, vol.12, issue.10, pp.1147-50, 2006. ,
The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice, Cardiovasc Res, vol.87, issue.1, pp.73-82, 2010. ,
Preclinical studies in the mdx mouse model of duchenne muscular dystrophy with the histone deacetylase inhibitor givinostat, Mol Med Camb Mass, vol.19, pp.79-87, 2013. ,
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment, Proc Natl Acad Sci, vol.105, issue.49, pp.19183-19190, 2008. ,
Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy, FASEB J Off Publ Fed Am Soc Exp Biol, vol.23, issue.7, pp.2131-2172, 2009. ,
Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice, EMBO Mol Med, vol.5, issue.4, pp.626-665, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01549090
Noncoding RNAs as epigenetic mediators of skeletal muscle regeneration, FEBS J, vol.282, issue.9, pp.1630-1676, 2015. ,
Noncoding RNAs: emerging players in muscular dystrophies, BioMed Res Int, p.503634, 2014. ,
Exercise, skeletal muscle and inflammation: ARE-binding proteins as key regulators in inflammatory and adaptive networks, Exerc Immunol Rev, vol.21, pp.42-57, 2015. ,
The birth of the Epitranscriptome: deciphering the function of RNA modifications, Genome Biol, vol.13, issue.10, p.175, 2012. ,
RNA modification and the epitranscriptome; the next frontier, RNA N Y N, vol.21, issue.4, pp.703-707, 2015. ,
Synthetic intron improves transduction efficiency of trans-splicing adeno-associated viral vectors, Hum Gene Ther, vol.17, issue.10, pp.1036-1078, 2006. ,
Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose, Mol Ther J Am Soc Gene Ther, vol.16, issue.2, pp.280-289, 2008. ,
RNA splicing: disease and therapy, Brief Funct Genomics, vol.10, issue.3, pp.151-64, 2011. ,
A day in the life of the spliceosome, Nat Rev Mol Cell Biol, vol.15, issue.2, pp.108-129, 2014. ,
Deep surveying of alternative splicing complexity in the human transcriptome by highthroughput sequencing, Nat Genet, vol.40, issue.12, pp.1413-1418, 2008. ,
A web-accessible complete transcriptome of normal human and DMD muscle, Neuromuscul Disord NMD, vol.12, issue.1, pp.125-166, 2002. ,
Trans-acting factors may cause dystrophin splicing misregulation in BMD skeletal muscles, FEBS Lett, vol.537, issue.1-3, pp.30-34, 2003. ,
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq, Nature, vol.485, issue.7397, pp.201-207, 2012. ,
Internal mRNA methylation finally finds functions, Science, vol.343, issue.6176, pp.1207-1215, 2014. ,
Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation, Science, vol.347, issue.6225, pp.1002-1008, 2015. ,
Lipid peroxidation and superoxide dismutase activity in muscle and erythrocytes in Duchenne muscular dystrophy, J Neurol Sci, vol.63, issue.3, pp.279-83, 1984. ,
Early onset of lipofuscin accumulation in dystrophindeficient skeletal muscles of DMD patients and mdx mice, J Mol Histol, vol.35, issue.5, pp.489-99, 2004. ,
Srinivas Bharath MM. Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism, Neurochem Res, vol.37, issue.4, pp.885-98, 2012. ,
Screening for increased protein thiol oxidation in oxidatively stressed muscle tissue, Free Radic Res, vol.45, issue.9, pp.991-1000, 2011. ,
Visualizing and quantifying oxidized protein thiols in tissue sections: a comparison of dystrophic mdx and normal skeletal mouse muscles. Free Radic Biol Med, vol.65, pp.1408-1424, 2013. ,
Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic Biol Med, vol.34, pp.1217-1237, 2003. ,
The identification and characterization of oxidized RNAs in Alzheimer's disease, J Neurosci Off J Soc Neurosci, vol.23, issue.12, pp.4913-4934, 2003. ,
Quantification of oxidized RNAs in Alzheimer's disease, Neurobiol Aging, vol.27, issue.5, pp.657-62, 2006. ,
Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS, PloS One, vol.3, issue.8, p.2849, 2008. ,
Increased systemic oxidatively generated DNA and RNA damage in schizophrenia, Psychiatry Res, vol.209, issue.3, pp.417-440, 2013. ,
Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles, Acta Neuropathol (Berl), vol.105, issue.6, pp.581-586, 2003. ,
Increased iron content and RNA oxidative damage in skeletal muscle with aging and disuse atrophy, Exp Gerontol, vol.43, issue.6, pp.563-70, 2008. ,
Oxidized messenger RNA induces translation errors, Proc Natl Acad Sci, vol.104, issue.1, pp.66-71, 2007. ,
Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression ,
, FASEB J Off Publ Fed Am Soc Exp Biol, vol.21, issue.11, pp.2753-64, 2007.
An active role for the ribosome in determining the fate of oxidized mRNA, Cell Rep, vol.9, issue.4, pp.1256-64, 2014. ,
Assessing the translational landscape of myogenic differentiation by ribosome profiling, Nucleic Acids Res, vol.43, issue.9, pp.4408-4436, 2015. ,
Protein carbonylation, cellular dysfunction, and disease progression, J Cell Mol Med, vol.10, issue.2, pp.389-406, 2006. ,
Specificity of age-related carbonylation of plasma proteins in the mouse and rat, Arch Biochem Biophys, vol.397, issue.2, pp.433-442, 2002. ,
Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases, J Biol Chem, vol.280, issue.12, pp.11648-55, 2005. ,
Protein oxidative modification in the aging organism and the role of the ubiquitin proteasomal system, Curr Pharm Des, vol.17, issue.36, pp.4007-4029, 2011. ,
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle, Nat Biotechnol, vol.28, issue.1, pp.79-82, 2010. ,
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector, Mol Ther J Am Soc Gene Ther, vol.20, issue.2, pp.443-55, 2012. ,
Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles, Mol Ther J Am Soc Gene Ther, vol.16, issue.7, pp.1252-60, 2008. ,
Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy, Methods Mol Biol Clifton NJ, vol.709, pp.127-166, 2011. ,
In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector, Cell Rep, vol.12, issue.6, pp.1056-68, 2015. ,
Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences, Nat Biotechnol, vol.17, issue.3, pp.241-246, 1999. ,
Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle, Mol Ther J Am Soc Gene Ther, vol.15, issue.2, pp.320-329, 2007. ,
Codon and mRNA sequence optimization of microdystrophin transgenes improves expression and physiological outcome in dystrophic mdx mice following AAV2/8 gene transfer, Mol Ther J Am Soc Gene Ther, vol.16, issue.11, pp.1825-1857, 2008. ,
Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy, Methods Mol Biol Clifton NJ, vol.709, pp.21-37, 2011. ,
, Restriction factors against rAAV in DMD muscles Journal Name, vol.0, p.17, 2015.
Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing, Mol Ther Nucleic Acids, vol.4, p.260, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01799968
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus, J Clin Invest, vol.105, issue.11, pp.1573-87, 2000. ,
Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation, Gene Ther, vol.12, issue.20, pp.1534-1542, 2005. ,
Enhancing transduction of the liver by adeno-associated viral vectors, Gene Ther, vol.16, issue.1, pp.60-69, 2009. ,
Polymers for improving the in vivo transduction efficiency of AAV2 vectors, PloS One, vol.5, issue.12, p.15576, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02495339
The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zincfinger nuclease-mediated gene targeting, Hum Gene Ther, vol.24, issue.1, pp.67-77, 2013. ,
Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins, Am J Pathol, vol.163, issue.4, pp.1663-75, 2003. ,
Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies, Am J Pathol, vol.176, issue.4, pp.1863-77, 2010. ,
Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery, Mol Ther J Am Soc Gene Ther, vol.12, issue.3, pp.441-50, 2005. ,
Combined effect of AAV-U7-induced dystrophin exon skipping and soluble activin Type IIB receptor in mdx mice, Hum Gene Ther, vol.23, issue.12, pp.1269-79, 2012. ,
Systemic delivery of genes to striated muscles using adeno-associated viral vectors, Nat Med, vol.10, issue.8, pp.828-862, 2004. ,
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice, Nat Med, vol.12, issue.7, pp.787-796, 2006. ,